StratDeckNOVN.SW

Novartis AG

NOVN.SW✓
Share

Healthcare · Drug Manufacturers - General · Switzerland

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Price113.92CHF
1D+1.68%
Market cap265B
AnalystsHold22
Next earnings27 Oct
Loading chart…

Trade ideas

NOVN.SW isn't in any strategy's Top Picks or Good Opportunities today.

Analysts

ConsensusHold22
Mean score2.65
Mean target125.44+10.12%
Target range104.18–151.98

Value vs sector peers

#8 of 26 in HealthcareCheap for a reason67
  • Fwd P/E14.272
  • P/B6.436
  • Yield3.3%78
  • P/E21.283
  • Rev growth+0.8%8

Nearest in Healthcare

  1. #6CVSCVS Health CorporationCheap for a reason77
  2. #7MDTMedtronic plcStronger than peers73
  3. #8NOVN.SWNovartis AGCheap for a reason67
  4. #9HCAHCA Healthcare, Inc.Stronger than peers60

Fundamentals

P/E21.2
Forward P/E14.2
Price / book6.43
Dividend yield3.30%
Beta0.49
52-week range96.03–132.6849/100
ADV (USD)440M
Relative volume1.3
10d avg volume4.09M
Revenue growth+0.80%
EPS growth-17.00%

Performance

1D+1.68%
7D-12.09%
1M-6.96%
3M-5.24%
6M-6.19%
YTD+7.10%

In the briefing and the feed

Briefing for 11 Sept

Neither the briefing nor the research feed has named NOVN.SW.

Catalysts

Next earnings: 27 Oct

Trade idea history

  • 8 SeptLong111.807Dpending2Wpending1Mpending

Get it by email

The board NOVN.SW sits on, in one five-minute email every weekday before the New York open and on Saturdays: market strength, the biggest movers, earnings coming up and the names sitting at their 200-day EMA.